Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer's disease (Q46121140)

19 December 2017

title

Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer's disease (English)

1 reference

19 December 2017

1 reference

3

1 reference

19 December 2017

author name string

Sönke Arlt

1

1 reference

19 December 2017

Stefanie Brassen

2

1 reference

19 December 2017

Florian Wilke

4

1 reference

19 December 2017

Martin Eichenlaub

5

1 reference

19 December 2017

Ivayla Apostolova

6

1 reference

19 December 2017

Fabian Wenzel

7

1 reference

19 December 2017

Frank Thiele

8

1 reference

19 December 2017

Stewart Young

9

1 reference

19 December 2017

Ralph Buchert

10

1 reference

19 December 2017

language of work or name

1 reference

14 February 2009

1 reference

19 December 2017

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

19 December 2017

volume

36

1 reference

19 December 2017

issue

7

1 reference

19 December 2017

page(s)

1090-1100

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/s00259-009-1063-7

exact match

0 references

cites work

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-009-1063-7

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-009-1063-7

What's wrong with Bonferroni adjustments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-009-1063-7

Compulsive behaviors as presenting symptoms of frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-009-1063-7

Assessment of accuracy of PET utilizing a 3-D phantom to simulate the activity distribution of [18F]fluorodeoxyglucose uptake in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-009-1063-7

Toward a molecular neuropsychiatry of neurodegenerative diseases

21 January 2018

1 reference

12 December 2020

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

1 reference

12 December 2020

Longitudinal changes of CSF biomarkers in memory clinic patients.

1 reference

12 December 2020

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease

1 reference

12 December 2020

Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis

1 reference

12 December 2020

CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease

1 reference

12 December 2020

FDG PET imaging in patients with pathologically verified dementia.

1 reference

12 December 2020

Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.

1 reference

12 December 2020

Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.

1 reference

12 December 2020

Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas.

1 reference

12 December 2020

Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI

1 reference

12 December 2020

CSF markers for incipient Alzheimer's disease

1 reference

12 December 2020

Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease.

1 reference

12 December 2020

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

1 reference

12 December 2020

Performance evaluation of the positron scanner ECAT EXACT

1 reference

12 December 2020

Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging.

1 reference

12 December 2020

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

1 reference

12 December 2020

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

1 reference

12 December 2020

Cerebrospinal fluid levels of amyloid beta-peptide1-42, but not tau have positive correlation with brain glucose metabolism in humans.

1 reference

12 December 2020

A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET

1 reference

12 December 2020

Severity of explicit memory impairment due to Alzheimer's disease improves effectiveness of implicit learning

1 reference

12 December 2020

Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints

1 reference

12 December 2020

Association of elevated phospho-tau levels with Alzheimer-typical 18F-fluoro-2-deoxy-D-glucose positron emission tomography findings in patients with mild cognitive impairment

1 reference

12 December 2020

Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat.

1 reference

12 December 2020

Reduced cerebral glucose metabolism and increased brain capillary permeability following high-dose methotrexate chemotherapy: a positron emission tomographic study

1 reference

12 December 2020

Interactive memory systems in the human brain

1 reference

12 December 2020

Competition among multiple memory systems: converging evidence from animal and human brain studies

1 reference

12 December 2020

Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.

1 reference

12 December 2020

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

1 reference

12 December 2020

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls

1 reference

12 December 2020

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

1 reference

12 December 2020

Change of cerebral glucose metabolism by antineoplastic drug.

1 reference

12 December 2020

Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia.

1 reference

12 December 2020

10.1007/S00259-009-1063-7

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

19219430

1 reference

19 December 2017